OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VALN56

Valiant Organics Ltd

Specialty ChemicalsVerified

Valiant Organics Ltd has a debt-to-equity ratio of 0.35, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity position is assessed as medium, with a current ratio of 1.0, suggesting that it has just enough current assets to cover its current liabilities. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed carefully. In terms of profitability, Valiant Organics Ltd reported a net loss of INR 172.19 million and an operating loss of INR 228.06 million in the latest period. The company's return on equity (ROE) is -2.36%, and its return on assets (ROA) is -1.38%, both of which are below the typical thresholds for healthy profitability in the specialty chemicals industry. These figures indicate that the company is currently not generating sufficient returns to cover its cost of capital or to satisfy equity investors. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risks if demand in its primary market or product line declines. There is no information available on the geographic distribution of its revenue, which limits the ability to assess regional exposure. Valiant Organics Ltd's growth trajectory is currently constrained by its financial performance. The company reported a net loss and an operating loss in the latest period, which suggests that it is not currently growing profitably. There is no data available on revenue growth or future outlook, making it difficult to assess the company's potential for future expansion or improvement in its financial position. The company's risk profile includes a medium liquidity risk, as indicated by its current ratio of 1.0 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. However, the company's financial performance, including its net loss and negative returns, could impact its ability to maintain or improve its capital structure without issuing additional shares or taking on more debt. Recent events related to Valiant Organics Ltd include the latest financial results, which show a net loss and an operating loss. There is no information available on recent filings or transcripts that would provide additional insight into the company's operations or strategic direction. The company's financial performance and capital structure suggest that it may need to take corrective actions to improve its profitability and liquidity position.

30-day price · VALN+70.17 (+29.7%)
Low$201.15High$319.00Close$306.20As of12 May, 00:00 UTC
Profile
CompanyValiant Organics Ltd
TickerVALN.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Valiant Organics Ltd is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

Classification. Valiant Organics Ltd is classified under the Basic Materials economic sector, within the Chemicals business sector and the Specialty Chemicals industry, with a classification confidence of 0.92.

Valiant Organics Ltd has a debt-to-equity ratio of 0.35, indicating a relatively conservative capital structure with a moderate level of leverage. The company's liquidity position is assessed as medium, with a current ratio of 1.0, suggesting that it has just enough current assets to cover its current liabilities. However, the company's net cash position is negative after subtracting total debt, which could pose a liquidity risk if not managed carefully. In terms of profitability, Valiant Organics Ltd reported a net loss of INR 172.19 million and an operating loss of INR 228.06 million in the latest period. The company's return on equity (ROE) is -2.36%, and its return on assets (ROA) is -1.38%, both of which are below the typical thresholds for healthy profitability in the specialty chemicals industry. These figures indicate that the company is currently not generating sufficient returns to cover its cost of capital or to satisfy equity investors. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher risks if demand in its primary market or product line declines. There is no information available on the geographic distribution of its revenue, which limits the ability to assess regional exposure. Valiant Organics Ltd's growth trajectory is currently constrained by its financial performance. The company reported a net loss and an operating loss in the latest period, which suggests that it is not currently growing profitably. There is no data available on revenue growth or future outlook, making it difficult to assess the company's potential for future expansion or improvement in its financial position. The company's risk profile includes a medium liquidity risk, as indicated by its current ratio of 1.0 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. However, the company's financial performance, including its net loss and negative returns, could impact its ability to maintain or improve its capital structure without issuing additional shares or taking on more debt. Recent events related to Valiant Organics Ltd include the latest financial results, which show a net loss and an operating loss. There is no information available on recent filings or transcripts that would provide additional insight into the company's operations or strategic direction. The company's financial performance and capital structure suggest that it may need to take corrective actions to improve its profitability and liquidity position.
Key takeaways
  • Valiant Organics Ltd has a debt-to-equity ratio of 0.35, indicating a relatively conservative capital structure.
  • The company reported a net loss of INR 172.19 million and an operating loss of INR 228.06 million in the latest period.
  • The company's return on equity (ROE) is -2.36%, and its return on assets (ROA) is -1.38%, both of which are below the typical thresholds for healthy profitability in the specialty chemicals industry.
  • Valiant Organics Ltd's liquidity position is assessed as medium, with a current ratio of 1.0.
  • The company's revenue is concentrated in a single business segment, with no significant geographic diversification reported.
  • The company's risk profile includes a medium liquidity risk and a low dilution risk.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's profitability is currently negative, with a net loss and an operating loss reported, indicating a need for improvement in cost management and pricing strategies.
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.77B
Gross profit$445.5M
Operating income-$228.1M
Net income-$172.2M
R&D
SG&A
D&A
SBC
Operating cash flow$838.4M
CapEx-$736.2M
Free cash flow
Total assets$12.48B
Total liabilities$5.19B
Total equity$7.29B
Cash & equivalents$34.8M
Long-term debt$2.57B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$7.55B$1.86B$1.15B-$288.5M
FY-3$11.53B$1.76B$1.13B$365.9M
FY-2$10.52B$1.40B$881.2M-$166.8M
FY-1$7.23B-$102.0k-$78.3M-$465.4M
FY0$7.19B$179.3M-$37.4M$15.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$8.76B$5.02B
FY-3$11.85B$6.13B
FY-2$12.39B$6.89B
FY-1$12.48B$7.29B
FY0$11.83B$7.25B-$1.0k
PeriodOCFCapExFCFSBC
FY-4$1.15B-$1.71B-$288.5M
FY-3-$324.7M-$1.21B$365.9M
FY-2$2.38B-$1.36B-$166.8M
FY-1$838.4M-$736.2M-$465.4M
FY0$564.3M-$308.3M$15.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.77B-$228.1M-$172.2M
FQ-6$1.68B$69.3M-$6.2M
FQ-5$1.60B-$64.3M-$127.8M
FQ-4$1.87B$63.4M$54.6M
FQ-3$2.04B$110.8M$42.0M
FQ-2$2.04B$154.1M$82.0M
FQ-1$1.57B$113.7M$56.7M
FQ0$1.59B$111.9M$36.5M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$12.48B$7.29B$34.8M
FQ-6
FQ-5$11.73B$7.16B$86.7M
FQ-4
FQ-3$11.83B$7.25B$71.0M
FQ-2
FQ-1$11.63B$7.40B$60.2M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$838.4M-$736.2M
FQ-6
FQ-5$820.6M-$168.5M
FQ-4
FQ-3$564.3M-$308.3M
FQ-2
FQ-1$922.4M-$124.9M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.29B
Net cash-$2.54B
Current ratio1.0
Debt/Equity0.3
ROA-1.4%
ROE-2.4%
Cash conversion-4.9%
CapEx/Revenue-41.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricVALNActivity
Op margin-12.9%8.0% medp25 -2.2% · p75 23.4%bottom quartile
Net margin-9.7%5.5% medp25 -3.8% · p75 18.5%bottom quartile
Gross margin25.2%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-41.6%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity35.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:36 UTC#945045cb
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 21:42 UTCJob: cb8147a5